Top Markets
Coin of the day
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.

NP5
Classificação em ações #15973
Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in... Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in Bresso, Milano, with a dedicated team of 24 full-time employees. The company's core mission is the discovery and advancement of innovative pharmaceutical products, particularly focusing on new therapies for Central Nervous System (CNS) disorders and pain management. Among its leading candidates, safinamide is currently undergoing Phase III clinical trials for the treatment of Parkinson's disease. Additionally, ralfinamide is being developed as a potential therapy for neuropathic pain. The firm's pipeline further includes a range of projects at various preclinical and clinical development stages, such as HF0220 for neuroprotection, NW-3509 for schizophrenia, and pruvanserin and sarizotan for other CNS conditions.
Preço da ação
$15.42
Valor de mercado
$320.83M
Variação (1 dia)
-1.52%
Variação (1 ano)
40.67%
País
IT
Negociar Newron Pharmaceuticals S.p.A. (NP5)

Categoria

Histórico de preços das ações de Newron Pharmaceuticals S.p.A. (NP5)
Preço de fecho mais alto: $15.42 em 2026-09-01

Preço de fecho mais baixo: $6.42 em 2019-07-01
Histórico de preços das ações da Newron Pharmaceuticals S.p.A. de 2019 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -24.46%
2025 190.90%
2024 71.92%
2023 246.71%
2022 -14.11%
2021 -28.37%
2020 -64.91%
2019 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$548.15 40.18%
US
$1.03K 44.14%
NL
$153.87 538.73%
US
$121.37 -11.93%
AU
$748.60 4.92%
CH